ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,607Medicare Part D Prescriptions Filled, Including Refills

Rank: 495 out of 6645

$617K Total Retail Price of All Prescriptions

Rank: 800 out of 6645

671 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 671 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,220 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 679 446 1 6
ACETAMINOPHEN-CODEINE 633 264 S3 2 80
AMLODIPINE BESYLATE 553 459 3 2
MELOXICAM 387 324 4 46
METFORMIN HCL 367 249 5 7
LOSARTAN POTASSIUM 341 241 6 12
LOVASTATIN 321 280 7 15
LOSARTAN-HYDROCHLOROTHIAZIDE 272 227 8 62
SIMVASTATIN 260 180 9 1
IBUPROFEN 218 120 10 42
ZOLPIDEM TARTRATE 210 103 11 17
TRIAMCINOLONE ACETONIDE 198 111 12 55
CARISOPRODOL 195 33 R 13 94
TRAMADOL HCL 189 85 14 30
TAMSULOSIN HCL 185 146 15 22
AZITHROMYCIN 176 119 16 44
HYDROCHLOROTHIAZIDE 156 89 17 9
CRESTOR 150 120 18 34
HYDROCODONE-ACETAMINOPHEN 145 34 S3 19 5
METOPROLOL TARTRATE 142 125 20 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 95 21 37
ATENOLOL 130 83 22 8
DIOVAN 130 115 22 19
DICLOFENAC SODIUM 127 95 24 109
GLIPIZIDE 117 98 25 23
PROAIR HFA 116 82 26 32
LISINOPRIL 112 84 27 3
DIOVAN HCT 111 102 28 64
SULFAMETHOXAZOLE-TRIMETHOPRIM 99 69 29 134
FUROSEMIDE 99 67 29 11
FLUTICASONE PROPIONATE 98 69 31 26
JANUVIA 98 83 31 38
GABAPENTIN 98 45 31 18
AMLODIPINE BESYLATE-BENAZEPRIL 91 32 34 97
BENAZEPRIL HCL 86 62 35 21
LEVOTHYROXINE SODIUM 86 64 35 4
ALENDRONATE SODIUM 85 75 37 14
VENTOLIN HFA 84 20 38 146
PENICILLIN V POTASSIUM 82 38 39 581
PLAVIX 78 70 40 49
INSULIN SYRINGE 77 50 41 61
CEPHALEXIN 75 31 42 111
JANUMET 71 64 43 132
ALLOPURINOL 70 51 44 31
CARVEDILOL 69 52 45 25
COMBIVENT 63 46 46 174
METOPROLOL SUCCINATE 61 48 47 24
AVODART 61 53 47 99
RANITIDINE HCL 60 48 49 51
CLOPIDOGREL 60 56 49 36
FELODIPINE ER 56 44 51 105
MECLIZINE HCL 56 45 51 122
ATORVASTATIN CALCIUM 56 31 51 10
CLONIDINE HCL 55 20 54 56
ADVAIR DISKUS 55 20 54 45
MEGESTROL ACETATE 54 40 R 56 104
LANTUS 54 30 56 50
GEMFIBROZIL 53 41 58 96
NEXIUM 52 49 59 40
CIPROFLOXACIN HCL 51 27 60 67
CYMBALTA 51 30 60 78
SYMBICORT 50 26 62 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.